Dexcom’s Innovative Diabetes Monitoring Device Recognized For Outstanding Achievement at Consumer Electronics Show (CES)
January 13 2014 - 2:20PM
Business Wire
Dexcom Wins Two Awards Including the
Everyday Health Award for Innovation
Dexcom (NASDAQ:DXCM), a leader in continuous glucose monitoring,
today announced that the Dexcom G4® PLATINUM, a continuous glucose
monitoring system, was named the winner of two awards that
recognize the device’s innovation, including the inaugural Everyday
Health Award for Innovation, which was presented by wellness
company, Everyday Health, and The 2014 International Consumer
Electronics Show (CES) Digital Summit.
The Dexcom G4 PLATINUM was honored in the Emerging Technology
category in a special live ceremony on January 9, 2014. Dexcom
Chief Executive Officer, Terrance H. Gregg accepted the award on
the company’s behalf. Dexcom was recognized among other innovative
digital health products, for their “outstanding achievement in
technology innovation aimed at improving overall health
outcomes.”
Dexcom was also recognized as one of the top 10 innovative
products at CES by the Tech Podcast Network. Mr. Gregg will be
featured in a podcast today, Friday, January 10, where he will be
interviewed on the success of the G4 PLATINUM and where the G4
PLATINUM ranks among other products being honored.
“We are humbled by the recognition that the Dexcom G4 PLATINUM
has received and especially in the presence of our peers at CES,
being included as part of a unique group on the cutting edge of
marrying creativity, science and technology,” said Terrance H.
Gregg, CEO, Dexcom. “At Dexcom we are proud of what we have
accomplished by taking technology and science a step further,
innovating on behalf of people with the serious and persistent
disease of diabetes.”
The Everyday Health Awards for Innovation selected three
finalists in five categories among over 140 entries of incredible
innovations and competitive products in the digital health
industry. The finalists were selected by an expert judging panel in
the digital health and wellness industry and consumers had the
opportunity to vote for their favorite products, which made up for
30 percent of the winner’s votes.
The Dexcom G4 PLATINUM tracks glucose levels continuously for 7
days throughout the 24-hour period using wireless technology,
enabling users to view their glucose levels on demand. The system
allows persons with diabetes to program personalized information,
such as glucose targets and alerts, and it has an alarm feature to
alert the user if glucose levels rise or fall to dangerous levels.
The Dexcom G4 PLATINUM is the only CGM that comes with a built-in
alarm that notifies users when glucose levels fall to critically
low levels for an additional level of awareness no other CGM brand
offers.
ABOUT DEXCOM, INC.
Dexcom, Inc., headquartered in San Diego, California, develops
and markets continuous glucose monitoring systems for use by
persons with diabetes, as well as blood glucose monitoring systems
used by healthcare providers in hospital critical care settings.
For more information on the Dexcom® CGM, visit www.dexcom.com.
BRIEF SAFETY STATEMENT
The Dexcom G4 PLATINUM Continuous Glucose Monitoring System is a
glucose monitoring device indicated for detecting trends and
tracking patterns in persons (age 18 and older) with diabetes.
CONTRAINDICATIONS: Remove the Dexcom G4 PLATINUM System before MRI,
CT scan, or diathermy treatment. Taking acetaminophen while wearing
the sensor may falsely raise your sensor glucose readings. WARNING:
Do not use the Dexcom G4 PLATINUM for treatment decisions. The
Dexcom G4 PLATINUM does not replace a blood glucose meter. If a
sensor breaks and no portion of it is visible above the skin, do
not attempt to remove it. Seek professional medical help if you
have infection or inflammation. Report broken sensors to Dexcom
Technical Support. The Dexcom G4 PLATINUM is not approved for use
in children or adolescents, pregnant women or persons on dialysis.
Sensor placement is not approved for sites other than under the
skin of the belly (abdomen). Contact Dexcom Toll Free at
877-339-2664 or www.dexcom.com for detailed indications for use and
safety information.
Consumer/Media:Green Room CommunicationsAlex Schnabel,
201-618-2735Alex@greenroompr.comorInvestor:Steven Pacelli,
858-200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From May 2024 to Jun 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Jun 2023 to Jun 2024